APEX1 / APE1

APE1 antibody LS-B10216 is an unconjugated mouse monoclonal antibody to human APE1 (APEX1). Validated for Flow, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues.

Antibodies Primary

Article No

LS-B10216-50

Species Reactivity

human

Size

50 µl

Clone

2A4

Source / Host

mouse

Shipping Information

RT

Application

FC, IF, IHC, WB

Article No

LS-B10216-50

Species Reactivity

human

Size

50 µl

Clone

2A4

Source / Host

mouse

Shipping Information

RT

Application

FC, IF, IHC, WB

Specifications

NCBI Number 328
Application FC, IF, IHC, WB
Article No LS-B10216-50
Country Availability SE, FI, DK, NO, FO, GL
Clone 2A4
Clone Type monoclonal
Concentration 1 mg/ml
Conjugation Unconjugated
Description APE1 antibody LS-B10216 is an unconjugated mouse monoclonal antibody to human APE1 (APEX1). Validated for Flow, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues.
Recommended Dilution FC (1:100), IF (1:100), IHC-P (10 ug/ml), WB (1:2000)
Supplier LifeSpan Biosciences
Entrez Gene ID 328
Gene Symbol APEX1
Immunogen Human recombinant protein fragment corresponding to amino acids 1-242 of human APEX1 (NP_001632) produced in E. coli.
Isotype IgG2a
Notes APE1 antibody LS-B10216 is an unconjugated mouse monoclonal antibody to human APE1 (APEX1). Validated for Flow, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues.
Alias Names APEX1, AP endonuclease class I, AP lyase, APE, APE-1, APEN, APE1, APEX nuclease, Redox factor-1, AP endonuclease 1, APEX, APX, Protein REF-1, REF-1, REF1
Product Type Antibodies Primary
Protocol Flo (1:100), IF (1:100), IHC, IHC-P (10 µg/ml), WB (1:2000)
Purification Protein A/G Purified
Shipping Information RT
Size 50 µl
Source / Host mouse
Species Reactivity human
Storage -20°C
Substrate / Buffer PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Technical Specifications Human APEX1 / APE1
Product Page Updated 2024-04-12T06:35:05.844Z
Volume 50 µl

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more